WANBURY
Back to Income Statement
|
WANBURY Last 5 Year Profit Before Tax History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Profit Before Tax | ₹30 Cr | ₹56 Cr | ₹-10 Cr | ₹81 Cr | ₹-12 Cr |
What is the latest Profit Before Tax of WANBURY ?
| Year | Profit Before Tax |
|---|---|
| Mar2025 | ₹30 Cr |
| Mar2024 | ₹56 Cr |
| Mar2023 | ₹-10 Cr |
| Mar2022 | ₹81 Cr |
| Mar2021 | ₹-12 Cr |
How is Profit Before Tax of WANBURY Trending?
| Years | Profit Before Tax | % Change | |
|---|---|---|---|
| Mar2025 | ₹30 Cr | -47.55 | |
| Mar2024 | ₹56 Cr | Positive | |
| Mar2023 | ₹-10 Cr | Negative | |
| Mar2022 | ₹81 Cr | Positive | |
| Mar2021 | ₹-12 Cr | - | |
Compare Profit Before Tax of peers of WANBURY
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| WANBURY | ₹675.5 Cr | 0.6% | -13% | -26.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹422,283.0 Cr | 0.1% | -5% | 5.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹244,762.0 Cr | -1.7% | 0.2% | 39.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹173,448.0 Cr | -2.5% | -5.5% | 30.2% | Stock Analytics | |
| CIPLA | ₹107,043.0 Cr | 0.9% | -2.6% | -14.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,820.0 Cr | 0.1% | 7.6% | -3.5% | Stock Analytics | |
WANBURY Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| WANBURY | 0.6% |
-13% |
-26.4% |
| SENSEX | 3.1% |
1% |
-9.1% |
You may also like the below Video Courses